Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Contineum Therapeutics (CTNM) Times Interest Earned (2023)

Historic Times Interest Earned for Contineum Therapeutics (CTNM) over the last 1 years, with Q2 2023 value amounting to $335.66.

  • Contineum Therapeutics' Times Interest Earned changed N/A to $335.66 in Q2 2023 from the same period last year, while for Mar 2024 it was $97.09, marking a year-over-year change of. This contributed to the annual value of $77.29 for FY2023, which is N/A changed from last year.
  • Latest data reveals that Contineum Therapeutics reported Times Interest Earned of $335.66 as of Q2 2023.
  • In the past 5 years, Contineum Therapeutics' Times Interest Earned ranged from a high of $335.66 in Q2 2023 and a low of -$55.6 during Q1 2023